Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    June 2018
  1. TAO Y, Auperin A, Sire C, Martin L, et al
    Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
    J Clin Oncol. 2018 Jun 7:JCO2017762518. doi: 10.1200/JCO.2017.76.2518.
    PubMed     Text format     Abstract available


    March 2018
  2. MA BBY, Lim WT, Goh BC, Hui EP, et al
    Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).
    J Clin Oncol. 2018 Mar 27:JCO2017770388. doi: 10.1200/JCO.2017.77.0388.
    PubMed     Text format     Abstract available


  3. BHATIA AK, Burtness BA, Decker RH
    Postoperative Chemoradiation in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    J Clin Oncol. 2018 Mar 16:JCO2018777987. doi: 10.1200/JCO.2018.77.7987.
    PubMed     Text format    


  4. PORCEDDU SV, Bressel M, Poulsen MG, Stoneley A, et al
    Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.
    J Clin Oncol. 2018 Mar 14:JCO2017770941. doi: 10.1200/JCO.2017.77.0941.
    PubMed     Text format     Abstract available


    February 2018
  5. THAI AA, Rischin D
    High-Dose Cisplatin for Head and Neck Cancer Lives On.
    J Clin Oncol. 2018 Feb 2:JCO2017768614. doi: 10.1200/JCO.2017.76.8614.
    PubMed     Text format    


    December 2017
  6. QUON H, Vapiwala N, Forastiere A, Kennedy EB, et al
    Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
    J Clin Oncol. 2017;35:4078-4090.
    PubMed     Text format     Abstract available


  7. FAKHRY C, Zhang Q, Nguyen-Tan PF, Rosenthal DI, et al
    Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
    J Clin Oncol. 2017;35:4057-4065.
    PubMed     Text format     Abstract available


  8. NORONHA V, Joshi A, Patil VM, Agarwal J, et al
    Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
    J Clin Oncol. 2017 Dec 8:JCO2017749457. doi: 10.1200/JCO.2017.74.9457.
    PubMed     Text format     Abstract available


    November 2017
  9. FORASTIERE AA, Ismaila N, Lewin JS, Nathan CA, et al
    Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    J Clin Oncol. 2017 Nov 27:JCO2017757385. doi: 10.1200/JCO.2017.75.7385.
    PubMed     Text format     Abstract available


  10. HO AS, Kim S, Tighiouart M, Gudino C, et al
    Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer.
    J Clin Oncol. 2017;35:3601-3609.
    PubMed     Text format     Abstract available


    October 2017
  11. VAN DEN WYNGAERT T, Helsen N, Carp L, Hakim S, et al
    Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
    J Clin Oncol. 2017;35:3458-3464.
    PubMed     Text format     Abstract available


  12. CABANILLAS ME, de Souza JA, Geyer S, Wirth LJ, et al
    Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial.
    J Clin Oncol. 2017;35:3315-3321.
    PubMed     Text format     Abstract available


    August 2017
  13. HSU C, Lee SH, Ejadi S, Even C, et al
    Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.
    J Clin Oncol. 2017 Aug 24:JCO2017733675. doi: 10.1200/JCO.2017.73.3675.
    PubMed     Text format     Abstract available


  14. BROSE MS, Worden FP, Newbold KL, Guo M, et al
    Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial.
    J Clin Oncol. 2017;35:2692-2699.
    PubMed     Text format     Abstract available


  15. EBISCH RMF, Rutten DWE, IntHout J, Melchers WJG, et al
    Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
    J Clin Oncol. 2017;35:2542-2550.
    PubMed     Text format     Abstract available


    May 2017
  16. PETTY RD, Dahle-Smith A, Stevenson DAJ, Osborne A, et al
    Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer.
    J Clin Oncol. 2017 May 24:JCO2016703934. doi: 10.1200/JCO.2016.70.3934.
    PubMed     Text format     Abstract available


  17. TRIFILETTI DM, Smith A, Mitra N, Grover S, et al
    Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
    J Clin Oncol. 2017;35:1550-1560.
    PubMed     Text format     Abstract available


  18. SZTURZ P, Seiwert TY, Vermorken JB
    How Standard Is Second-Line Cetuximab in Recurrent or Metastatic Head and Neck Cancer in 2017?
    J Clin Oncol. 2017 May 4:JCO2016718072. doi: 10.1200/JCO.2016.71.8072.
    PubMed     Text format    


    March 2017
  19. BAUML J, Seiwert TY, Pfister DG, Worden F, et al
    Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.
    J Clin Oncol. 2017 Mar 22:JCO2016701524. doi: 10.1200/JCO.2016.70.1524.
    PubMed     Text format     Abstract available


    February 2017
  20. NEKHLYUDOV L, Lacchetti C, Davis NB, Garvey TQ, et al
    Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline.
    J Clin Oncol. 2017 Feb 27:JCO2016718478. doi: 10.1200/JCO.2016.71.8478.
    PubMed     Text format     Abstract available


  21. MARUR S, Li S, Cmelak AJ, Gillison ML, et al
    E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
    J Clin Oncol. 2017;35:490-497.
    PubMed     Text format     Abstract available


  22. BARTLEY AN, Washington MK, Colasacco C, Ventura CB, et al
    HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.
    J Clin Oncol. 2017;35:446-464.
    PubMed     Text format     Abstract available


    January 2017
  23. FERRAROTTO R, Mitani Y, Diao L, Guijarro I, et al
    Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    J Clin Oncol. 2017;35:352-360.
    PubMed     Text format     Abstract available


    December 2016
  24. RIBASSIN-MAJED L, Marguet S, Lee AW, Ng WT, et al
    What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.
    J Clin Oncol. 2016 Dec 5:JCO2016674119.
    PubMed     Text format     Abstract available


  25. JANSEN F, Krebber AM, Coupe VM, Cuijpers P, et al
    Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.
    J Clin Oncol. 2016 Dec 5:JCO2016688739.
    PubMed     Text format     Abstract available


    September 2016
  26. CHOW LQ, Haddad R, Gupta S, Mahipal A, et al
    Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.
    J Clin Oncol. 2016 Sep 19. pii: JCO681478.
    PubMed     Text format     Abstract available


    August 2016
  27. ACEVEDO JR, Fero KE, Wilson B, Sacco AG, et al
    Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.
    J Clin Oncol. 2016 Aug 22. pii: JCO684563.
    PubMed     Text format     Abstract available


  28. DIVI V, Chen MM, Nussenbaum B, Rhoads KF, et al
    Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer.
    J Clin Oncol. 2016 Aug 1. pii: JCO673863.
    PubMed     Text format     Abstract available


    May 2016
  29. LI J, Qin S, Xu J, Xiong J, et al
    Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
    J Clin Oncol. 2016;34:1448-54.
    PubMed     Text format     Abstract available


    April 2016
  30. WIRTH LJ
    Cetuximab in Human Papillomavirus-Positive Oropharynx Carcinoma.
    J Clin Oncol. 2016;34:1289-91.
    PubMed     Text format    


  31. SABA NF, Wong SJ
    Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out?
    J Clin Oncol. 2016 Apr 11. pii: JCO669085.
    PubMed     Text format    


  32. CARMONA R, Zakeri K, Green G, Hwang L, et al
    Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events.
    J Clin Oncol. 2016;34:1270-7.
    PubMed     Text format     Abstract available


  33. PATEL S, Ragab O, Demanes DJ, Chen AM, et al
    Brachytherapy: Where Has It Gone...Again?
    J Clin Oncol. 2016;34:1155.
    PubMed     Text format    


  34. RINGASH J
    Reply to N. Osazuwa-Peters et al.
    J Clin Oncol. 2016;34:1152.
    PubMed     Text format    


    March 2016
  35. KIM S
    Head and Neck Radiation Oncology: Is Busier Better?
    J Clin Oncol. 2016;34:653-4.
    PubMed     Text format    


    February 2016
  36. LOPES LF, Macedo CR, Aguiar Sdos S, Barreto JH, et al
    Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
    J Clin Oncol. 2016;34:603-10.
    PubMed     Text format     Abstract available


  37. HECHT JR, Bang YJ, Qin SK, Chung HC, et al
    Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.
    J Clin Oncol. 2016;34:443-51.
    PubMed     Text format     Abstract available


  38. KHOT A, Love C, Garg MK, Haigentz M Jr, et al
    Long-Term Disease Control in a Patient With Recurrent Bone-Only Oligometastatic Nasopharyngeal Carcinoma.
    J Clin Oncol. 2016;34:e25-6.
    PubMed     Text format    


    January 2016
  39. THEKKEKARA R, Udayagiri VS, Patel U, Goldberg D, et al
    Depression and smoking patterns among head and neck cancer patients in an inner city minority population.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  40. MCQUESTION M, Sampson L, Le LW, Jones JM, et al
    Partner's survivorship care needs: Multivariable analysis in head and neck cancer patients.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  41. FELIX C, Hsu S
    Patient- versus physician-reported toxicities among survivors of head and neck cancer after chemoradiation: Prospective evaluation of screening methodologies.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  42. SHINN EH, Garden AS, Patrick K, Shete S, et al
    Identifying dehydration risk in head and neck cancer patients undergoing radiation therapy using remote, sensor-based monitoring: A randomized controlled trial.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  43. BAYOUMI Y, Senosy MA, Elawadi AA, AlHussain H, et al
    Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy in Saudi Arabia.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  44. BODMANN J, Koyfman SA, Nwizu TI, Joshi NP, et al
    Measuring impact of survivorship care plans on head and neck cancer patients.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  45. OSAZUWA-PETERS N, Adjei Boakye E, Walker RJ, Varvares MA, et al
    Suicide: A Major Threat to Head and Neck Cancer Survivorship.
    J Clin Oncol. 2016 Jan 19. pii: JCO654673.
    PubMed     Text format    


  46. BOERO IJ, Paravati AJ, Xu B, Cohen EE, et al
    Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.
    J Clin Oncol. 2016 Jan 4. pii: JCO639898.
    PubMed     Text format     Abstract available


    December 2015
  47. ROSENTHAL DI, Harari PM, Giralt J, Bell D, et al
    Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Witho
    J Clin Oncol. 2015 Dec 28. pii: JCO625970.
    PubMed     Text format     Abstract available


  48. JANJIGIAN YY
    Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?
    J Clin Oncol. 2015 Dec 23. pii: JCO642892.
    PubMed     Text format    


  49. MAGRINI SM, Buglione M, Corvo R, Pirtoli L, et al
    Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
    J Clin Oncol. 2015 Dec 7. pii: JCO631671.
    PubMed     Text format     Abstract available


  50. HUSAIN ZA, Burtness BA, Decker RH
    Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
    J Clin Oncol. 2015 Dec 7. pii: JCO647586.
    PubMed     Text format    


    November 2015
  51. MURPHY CT, Galloway TJ, Handorf EA, Egleston BL, et al
    Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
    J Clin Oncol. 2015 Nov 30. pii: JCO615906.
    PubMed     Text format     Abstract available


  52. MURPHY C, Schwalb H, Berlangieri S, Eek R, et al
    Intraluminal Superior Vena Cava Metastasis in a Patient With Poorly Differentiated Thyroid Carcinoma.
    J Clin Oncol. 2015;33:e119-21.
    PubMed     Text format    


  53. TURCOTTE LM, Whitton JA, Friedman DL, Hammond S, et al
    Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    J Clin Oncol. 2015;33:3568-75.
    PubMed     Text format     Abstract available


    October 2015
  54. GALLOWAY TJ, Ridge JA
    Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site.
    J Clin Oncol. 2015;33:3328-37.
    PubMed     Text format     Abstract available


  55. DILLON MT, Harrington KJ
    Human Papillomavirus-Negative Pharyngeal Cancer.
    J Clin Oncol. 2015;33:3251-61.
    PubMed     Text format     Abstract available


  56. BHATIA A, Burtness B
    Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.
    J Clin Oncol. 2015;33:3243-50.
    PubMed     Text format     Abstract available


  57. BRUCE JP, Yip K, Bratman SV, Ito E, et al
    Nasopharyngeal Cancer: Molecular Landscape.
    J Clin Oncol. 2015;33:3346-55.
    PubMed     Text format     Abstract available


  58. HOLSINGER FC, Ferris RL
    Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials.
    J Clin Oncol. 2015;33:3285-92.
    PubMed     Text format     Abstract available


  59. CHINN SB, Myers JN
    Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.
    J Clin Oncol. 2015;33:3269-76.
    PubMed     Text format     Abstract available


  60. HUANG SH, Xu W, Waldron J, Hope AJ, et al
    Reply to J.J. Beitler et al.
    J Clin Oncol. 2015;33:3218-9.
    PubMed     Text format    


  61. BEITLER JJ, LeCraw Mikell J, Switchenko J
    Human Papillomavirus-Related Oropharyngeal Cancer: Agree With a New Staging System, but the Devil Is in the Details.
    J Clin Oncol. 2015;33:3217-8.
    PubMed     Text format    


    September 2015
  62. BORGET I, Bonastre J, Catargi B, Deandreis D, et al
    Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial.
    J Clin Oncol. 2015;33:2885-92.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: